Advertisement

Amniotic Fluid: Biochemical Assays Relating to Fetal Viability

  • Laszlo Sarkozi

Abstract

The selection of this body fluid for inclusion in this book is self-explanatory. This chapter attempts to describe reasons for obtaining the amniotic fluid; its composition, which depends on its origin; and the great wealth of information on the well-being of the fetus obtained by performing biochemical assays of amniotic fluid. References on cytologic, histochemi-cal, and biochemical studies of suspended cells obtained from amniotic fluid are listed and intended as background information in the pursuit of further studies. Most of these studies today are performed only by investigators and some research-oriented laboratories. However, they conduct successful screening programs for the most frequent fetal biochemical disorders and the research tools of yesterday are the routine tests of today.

Keywords

Obstet Gynecol Amniotic Fluid Antenatal Diagnosis Maple Syrup Urine Disease Amniotic Fluid Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abramov A, Schore S, Wolman M (1956) Generalized xanthomatosis with calcified adrenals. Am J Dis Child 91: 282Google Scholar
  2. 2.
    Aburel MD (1937) Le declenchement du travail par injections intraamniotique de serum sale hypertoni-que. Gynecol Obstet 36: 398Google Scholar
  3. 3.
    Adams FH, Fujiwara T, Emmanouilides GC Raiha N (1970) Lung phospholipids of human fetuses and infants with and without hyaline membrane disease. J Pediatr 77: 833PubMedCrossRefGoogle Scholar
  4. 4.
    Alcindor LG, Bereziat G, Vielh JP, Gautray JP (1974) Le rapport de concentration acide palmitique sur acide stearique, indicateur de la maturite pulmonaire foetale. Clin Chim Acta 50: 31PubMedCrossRefGoogle Scholar
  5. 5.
    Allan JD, Cusworth DC, Dent CE, Wilson VK (1958) A disease, probably hereditary, characterized by severe mental deficiency and a constant gross abnormality of amino acid metabolism. Lancet i: 182CrossRefGoogle Scholar
  6. 6.
    Alvey JP (1964) Obstetrical management of Rh incompatibility based on liquor amnii studies. Am J Obstet Gynecol 90: 769PubMedGoogle Scholar
  7. 7.
    Andersen DH (1952) Studies on glycogen disease with a report of a case in which the glycogen was abnormal. In Symposium on the Clinical and Biochemical Aspects of Carbohydrate Utilization in Health and Disease, Najjar VA (ed) Baltimore, Johns Hopkins Press, p 28Google Scholar
  8. 8.
    Austin J (1963) Studies in globoid (Krabbe) leukodystrophy. I. The significance of lipid abnormalities in white matter in 8 globoid and 13 control patients. Arch Neurol 9: 207PubMedCrossRefGoogle Scholar
  9. 9.
    Austin J (1965) Mental retardation: Globoid (Krabbe) leukodystrophy. In Medical Aspects of Mental Retardation. Carter CH (ed) Springfield, Ill., Charles C Thomas, p 813Google Scholar
  10. 10.
    Austin J, Armstrong D, Shearer L (1965) Metachromatic form of diffuse cerebral sclerosis. V. The nature and significance of low sulfatase activity: a controlled study of brain, liver and kidney in four patients with metachromatic leukodystrophy (MLD). Arch Neurol 13: 593Google Scholar
  11. 11.
    Austin J, Armstrong D, Shearer L, McAfee D (1966) Metachromatic form of diffuse cerebral sclerosis. VI. A rapid test for sulfatase A deficiency in metachromatic leukodystrophy urine. Arch Neurol 14: 259PubMedCrossRefGoogle Scholar
  12. 12.
    Austin J, Suzuki K, Armstrong D, Brady R, Bach-hawat BK, Schlenker J, Stumpf D (1970) Studies in globoid (Krabbe) leukodystrophy (GLD). Arch Neurol 23: 502PubMedCrossRefGoogle Scholar
  13. 13.
    Avery ME, Mead J (1959) Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 97: 517Google Scholar
  14. 14.
    Barber GW, Speath GL (1967) Pyridoxine therapy in homocystinuria. Lancet i: 337Google Scholar
  15. 15.
    Barton RW, Neufeld EF (1972) A distinct biochemical deficit in the Maroteaux-Lamy syndrome (mucopolysaccharidosis VI). J Pediatr 80: 114CrossRefGoogle Scholar
  16. 16.
    Baughan MA, Valentine WN, Paglia DE, Ways PO, Simons ER, DeMarsh AB (1968) Hereditary hemolytic anemia associated with glucose-phosphate isomerase (GPI) deficiency—a new enzyme defect of human erythrocytes. Blood 32: 236PubMedGoogle Scholar
  17. 17.
    Baum H, Dodgson KS, Spencer B (1959) The assay of arylsulfatases A and B in human urine. Clin Chim Acta 4: 453PubMedCrossRefGoogle Scholar
  18. 18.
    Beam AG (ed) (1969) Symposium on the mucopolysaccharidoses. Am J Med 47: 661CrossRefGoogle Scholar
  19. 19.
    Becroft DMO, Phillips LI (1965) Hereditary orotic aciduria and megaloblastic anaemia: A second case, with response to uridine. Br Med J 1: 547PubMedCrossRefGoogle Scholar
  20. 20.
    Benson PF, Bowser-Riley F, Giannelli F (1970) β-galactosidases in fibroblasts: Hurler and Sanfilippo syndromes. N Engl J Med 283: 999PubMedCrossRefGoogle Scholar
  21. 21.
    Berman PHA (1969) A method for the prenatal diagnosis of congenital hyperuricemia. J Pediatr 75: 488PubMedCrossRefGoogle Scholar
  22. 22.
    Bernheimer H, Scitelberger F (1968) Uber das verhalten der ganglioside im gehirn bei 2 Fallern von spatinfantiler amaurotischer idiotie. Wien Klin Wochenschr 80: 163PubMedGoogle Scholar
  23. 23.
    Beutler E, Baluda MC, Sturgeon P, Day R (1965) A new genetic abnormality resulting in galactose-1-phosphate uridyltransferase deficiency. Lancet i: 353Google Scholar
  24. 24.
    Beutler E, Kuhl W, Trinidad R, Teplitz R, Nadler H (1971) β-Glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher’s disease. Am J Hum Genet 23: 62Google Scholar
  25. 25.
    Bevis DCA (1952) The antenatal prediction of hae-molytic disease of the newborn. Lancet i: 395Google Scholar
  26. 26.
    Bhagwanani SG, Fahmy D, Turnbull AC (1972) Prediction of neonatal respiratory distress by estimation of amniotic fluid lecithin. Lancet i: 159Google Scholar
  27. 27.
    Bhagwanani SG, Fahmy D, Turnbull AC (1972) Quick determination of amniotic fluid lecithin concentration for prediction of neonatal respiratory distress. Lancet ii: 66Google Scholar
  28. 28.
    Bickel H, Baur HS, Astley R, Douglas AA, Finch E, Harris H, Harvey CC, Hickmans EM, Philpott MG, Smallwood WC, Smellie JM, Teall CG (1952) Cystine storage disease with amino aciduria and dwarfism (Lignac-Fanconi disease). Acta Paediatr (Suppl 90) 42: 7Google Scholar
  29. 29.
    Bieniarz J (1974) Diagnostic value of ultrasonography in obstetrics and amniotic fluid sampling. In Amniotic Fluid, Natelson S, Scommegna A, Epstein MB (eds) New York: John Wiley and Sons, pp 205–212Google Scholar
  30. 30.
    Biezenski JJ (1973) Origin of amniotic fluid lipids. III. Fatty acids. Proc Soc Exp Biol Med 142: 1326PubMedCrossRefGoogle Scholar
  31. 31.
    Biezenski JJ, Pomerance W, Goodman J (1968) Studies on the origin of amniotic fluid lipids. I. Normal composition. Am J Obstet Gynecol 102: 853PubMedGoogle Scholar
  32. 32.
    Biggs JSG, Gaffney TJ, McGeary HM (1973) Evidence that fetal lung fluid and phospholipids pass into amniotic fluid in late human pregnancy. J Obstet Gynecol 80: 125Google Scholar
  33. 33.
    Bischoff A, Ulrich J (1969) Peripheral neuropathy in globoid cell leukodystrophy (Krabbe’s disease): Ultra-structural and histochemical findings. Brain 92: 861PubMedCrossRefGoogle Scholar
  34. 34.
    Blass JP, Avigan J, Uhlendorf BW (1940) A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 49: 423CrossRefGoogle Scholar
  35. 35.
    Blass JP, Thibert RJ, Fraisey TF (1973) Simple, rapid determination of lecithin and sphingomyelin in amniotic fluid. Clin Chem 19: 1394PubMedGoogle Scholar
  36. 36.
    Blume RS, Glade PR, Gralnick HR, Chessin LN, Haase AT, Wolff SM (1969) The Chediak-Higashi syndrome: Continuous suspension cultures derived from peripheral blood. Blood 33: 821Google Scholar
  37. 37.
    Blumenfeld TA (1975) Clinical laboratory tests for fetal lung maturity. In Pathology Annual. Sommers SC (ed) New York, Appleton-Century-Crofts, pp 21–36Google Scholar
  38. 38.
    Blumenfeld TA, Cheskin HS, Shinitzky M (1979) Microviscosity of amniotic fluid phospholipids and its importance in determining fetal lung maturity. Clin Chem 25: 64PubMedGoogle Scholar
  39. 39.
    Bonsnes RW (1965) Model 202. Analysis of bilirubin content of amniotic fluid. Instrum. News—The Perkin Elmer Corp. 16: 14Google Scholar
  40. 40.
    Bonsnes RW (1972) The chemistry and physiology of amniotic fluid. In Antenatal Diagnosis. Dorfman A (ed) Chicago, The University of Chicago Press, pp 3–16Google Scholar
  41. 41.
    Brady RO (1968) Enzymatic defects in the sphin-golipidoses. Adv Clin Chem 11: 1PubMedCrossRefGoogle Scholar
  42. 42.
    Brady RO (1969) Genetics and the sphingolipi-doses. Med Clin North Am 53: 827PubMedGoogle Scholar
  43. 43.
    Brady RO, Gal AI, Bradley RM, Martensson, E, Warshaw AL, Laster L (1967) Enzymatic defect in Fabry’s disease: Ceramidetrihexosidase deficiency. N Engl J Med 276: 1163PubMedCrossRefGoogle Scholar
  44. 44.
    Brady RO, Johnson WG, Uhlendorf BW (1971) Identification of heterozygous carriers by lipid storage disease. Am J Med 51: 423PubMedCrossRefGoogle Scholar
  45. 45.
    Brady RO, Kanfer JN, Bradley RM, Shapiro D (1966) Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher’s disease. J Clin Invest 45: 1112PubMedCrossRefGoogle Scholar
  46. 46.
    Brady RO, Kanfer JN, Shapiro D (1965) Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher’s disease. Biochem Biophys Res Commun 18: 221PubMedCrossRefGoogle Scholar
  47. 47.
    Brady RO, Uhlendorf BW, Jacobson CB (1971) Fabry’s disease: Antenatal detection. Science 172: 174PubMedCrossRefGoogle Scholar
  48. 48.
    Brock DJH (1972) Inborn errors of metabolism. In The Biochemical Genetics of Man, Brock, DJH, Mayo O (eds) London, Academic Press, pp 385–476Google Scholar
  49. 49.
    Brock DJH, Gordon H, Seligman S, De H Lobo E (1971) Antenatal detection of Hurler’s syndrome. Lancet ii: 1324Google Scholar
  50. 50.
    Brock DJH, Sutcliffe RD (1972) α-Fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet ii: 197CrossRefGoogle Scholar
  51. 51.
    Brown AK (1968) Constituents of amniotic fluid: Reflections of normal and abnormal fetal maturation. In Diagnosis and Treatment of Fetal Disorders, Adamson K (ed) New York: Springer-Verlag, pp 121–140CrossRefGoogle Scholar
  52. 52.
    Brubaker RF, Wong VG, Schulman JD, Seegmiller JE, Kuwabara T (1970) Benign cystinosis. Am J Med 49: 546PubMedCrossRefGoogle Scholar
  53. 53.
    Brunberg JA, McCormick WF, Schochet SS (1971) Type III glycogenosis. Arch Neurol 25: 171PubMedCrossRefGoogle Scholar
  54. 54.
    Cantz M, Chambach A, Neufeld EF (1970) Characterization of the factor deficient in the Hunter syndrome by Polyacrylamide gel electrophoresis. Biochem Biophys Res Commun 39: 936PubMedCrossRefGoogle Scholar
  55. 55.
    Cassidy G (1974) Amniocentesis. In Clinics in Perinatology, Nesbitt REL (ed) Philadelphia: W. B. Saunders Co., Vol 1:1, pp 87–123Google Scholar
  56. 56.
    Cathro DM, Bertrand J, Coyle MG (1969) Antenatal diagnosis of adrenocortical hyperplasia. Lancet i: 732Google Scholar
  57. 57.
    Chayoth R, Moses SW, Steinitz K (1967) De brancher enzyme activity in blood cells of families with type III glycogen storage disease: A method for diagnosis of heterozygotes. Isr J Med Sci 3: 433Google Scholar
  58. 58.
    Cherry SH, Kochwa S, Rosenfield RE (1965) Bilirubin—protein ratio in amniotic fluid as an index of the severity of erythroblastosis fetalis. Obstet Gynecol 26: 826PubMedGoogle Scholar
  59. 59.
    Cherry SH, Rosenfield RE (1967) Intrauterine fetal transfusions for the management of erythroblastosis. Am J Obstet Gynecol 98: 275PubMedGoogle Scholar
  60. 60.
    Childs B, Nyhan WL, Borden M, Bard L, Cooke RE (1961) Idiopathic hyperglycinemia and hyperglycinu-ria: A new disorder of amino acid metabolism. J Pediatr 27: 522Google Scholar
  61. 61.
    Cleaver JE (1968) Defective repair application of DNA in xeroderma pigmentosum. Nature (London) 218: 652CrossRefGoogle Scholar
  62. 62.
    Cleaver JE (1969) Xeroderma pigmentosum: A human disease in which an initial stage of DNA repair is defective. Proc Natl Acad Sci USA 63: 428PubMedCrossRefGoogle Scholar
  63. 63.
    Clements JA, Platzker ACG, Tierney DF, Hobel CT, Creasy RK, Margolis AJ, Thibeault DW, Tooley WH Oh W (1972) Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid. N Engl J Med 286: 1077PubMedCrossRefGoogle Scholar
  64. 64.
    Goch E, Kessler G (1972) Rapid TLC separation and detection of lecithin and sphingomyelin in amniotic fluid. Clin Chem 18: 490Google Scholar
  65. 65.
    Coch E, Kessler G, Meyer JS (1974) Rapid thin-layer chromatographic method for assessing the lecithin/ sphingomyelin ratio in amniotic fluid. Clin Chem 20: 1368PubMedGoogle Scholar
  66. 66.
    Cox RP, Douglas G, Hutzler J, Lynfield J, Dancis J (1970) In-utero detection of Pompe’s disease. Lancet i: 893CrossRefGoogle Scholar
  67. 67.
    Crocker AC (1961) The cerebral defect in Tay-Sachs disease and Niemann-Pick disease. J Neurochem 7: 69PubMedCrossRefGoogle Scholar
  68. 68.
    Curbello V, Gail DB, Farrel PM (1978) Determination of disaturated lecithin in rhesus monkey amniotic fluid as an index of fetal lung maturity. Am J Obstet Gynecol 131: 764Google Scholar
  69. 69.
    Dancis J (1968) The antepartum diagnosis of genetic diseases. J Pediatr 72: 301PubMedCrossRefGoogle Scholar
  70. 70.
    Dancis J, Cox RP, Berman PH, Jansen V, Balis MW (1969) Cell population density and phenotypic expression of tissue culture fibroblasts from heterozygotes of Lesch-Nyhan’s disease (inosinate pyrophosphorylase deficiency). Biochem Genet 3: 609PubMedCrossRefGoogle Scholar
  71. 71.
    Dancis J, Hutzler J, Cox RP (1969) Enzyme defect in skin fibroblasts in intermittent branched-chain ketonuria and in maple syrup urine disease. Biochem Med 2: 407CrossRefGoogle Scholar
  72. 72.
    Dancis J, Hutzler J, Cox RP, Woody NC (1969) Familial hyperlysinemia with lysine-ketoglutarate reductase deficiency. J Clin Invest 48: 1447PubMedCrossRefGoogle Scholar
  73. 73.
    Dancis J, Hutzler J, Levitz M (1965) Detection of the heterozygote in maple sugar urine disease. J Pediatr 66: 595PubMedCrossRefGoogle Scholar
  74. 74.
    Dancis J, Hutzler J, Lynfield J, Cox RP (1969) Absence of acid maltase in glycogenosis type 2 (Pompe’s disease) in tissue culture. Am J Dis Child 117: 108PubMedGoogle Scholar
  75. 75.
    Dancis J, Hutzler J, Tada K, Wada Y, Morikawa T, Arakawa T (1967) Hypervalinemia: A defect in valine transamination. Pediatrics 39: 813PubMedGoogle Scholar
  76. 76.
    Dancis J, Jansen V, Hutzler J, Levitz M (1963) The metabolism of leucine in tissue culture of skin fibroblasts of maple syrup urine disease. Biochem Biophys Acta 77: 523PubMedCrossRefGoogle Scholar
  77. 77.
    Danes BS, Beam AG (1966) Hurler’s syndrome: A genetic study in cell culture. J Exp Med 123: 1PubMedCrossRefGoogle Scholar
  78. 78.
    Danes BS, Beam AG (1967) Cell culture and the Chediak-Higashi syndrome. Lancet ii: 65CrossRefGoogle Scholar
  79. 79.
    Danes BS, Beam AG (1968) A genetic cell marker in cystic fibrosis of the pancreas. Lancet i: 1061Google Scholar
  80. 80.
    Danes BS, Beam AG (1969) Cystic fibrosis of the pancreas: A study in cell culture. J Exp Med 129: 775PubMedCrossRefGoogle Scholar
  81. 81.
    Danes BS, Beam AG (1970) Correction of cellular metachromasia in cultured fibroblasts in several inherited mucopolysaccharidoses. Proc Natl Acad Sci USA 67: 357PubMedCrossRefGoogle Scholar
  82. 82.
    Danes BS, Queenan JT, Gadow EC, Cederqvist LL (1970) Antenatal diagnosis of mucopolysaccharidoses. Lancet i: 946CrossRefGoogle Scholar
  83. 83.
    Daum RS, Marner OA, Lamm PH, Scriver CR (1971) A “new” disorder of isoleucine catabolism. Lancet ii: 1289CrossRefGoogle Scholar
  84. 84.
    Davidson RG, Nitowsky HM, Childs B (1963) Demonstration of two populations of cells in the human female heterozygous for glucose-6-phosphate dehydrogenase variants. Proc Natl Acad Sci USA 50: 481PubMedCrossRefGoogle Scholar
  85. 85.
    Dawson G, Stein AO (1970) Lactosyl ceramidosis: Catabolic enzyme defect of glycosphingolipid metabolism. Science 170: 556Google Scholar
  86. 86.
    Dawson G, Stein AO (1971) Lactosyl ceramidosis: Characterization of a new glycosphingolipidosis. In: Lipid Storage Diseases: Enzymatic Defects and Clinical Implications, Bernsohn J (ed) New York, Academic Press, pp 183–201Google Scholar
  87. 87.
    DeMars R, Leroy JG (1966) The remarkable cells cultured from a human with Hurler’s syndrome. In: In Vitro, Phenotypic Expression, Dawe CJ (ed) Baltimore, Williams and Wilkins, Vol. 2, pp 107–118Google Scholar
  88. 88.
    Derry DM, Fawcett JS, Andermann F, Wolfe LS (1968) Late infantile systemic lipidosis. Major monosialo-gangliosidosis. Delineation of two types. Neurology 18: 340PubMedCrossRefGoogle Scholar
  89. 89.
    Di Ferrante N, Donnelly PV, Neri G (1971) Metabolism of glycosaminoglycans in cultured normal and abnormal human fibroblasts. Biochem Med 5: 269PubMedCrossRefGoogle Scholar
  90. 90.
    Dorfman A (ed) (1972) Antenatal Diagnosis. Chicago, University of Chicago PressGoogle Scholar
  91. 91.
    Durand P, Borrone C, Della Cella G (1969) Fucosi-dosis. J Pediatr 75: 665CrossRefGoogle Scholar
  92. 92.
    Eeg-Olofsson O, Kristensson K, Sourander P, Svennerholm L (1966) Tay-Sachs disease: A generalized metabolic disorder. Acta Paediatr Scand 55: 546PubMedCrossRefGoogle Scholar
  93. 93.
    Ekelund L, Arvidson G, Astedt B (1973) Amniotic fluid lecithin and its fatty acid composition in respiratory distress syndrome. J Obstet Gynaecol Br Commonw 80: 912PubMedCrossRefGoogle Scholar
  94. 94.
    Emery AEH (1973) Biochemical analysis of amniotic fluid. In Antenatal Diagnosis of Genetic Disease, Emery AEH (ed) Baltimore, Williams and Wilkins Company, pp 113–136Google Scholar
  95. 95.
    Epstein CJ, Brady RO, Schneider RM, Bradley D, Shapiro D (1971) In utero diagnosis of Niemann-Pick disease. Am J Hum Genet 23: 533PubMedGoogle Scholar
  96. 96.
    Fairweather DVI, Eskes TKAB (eds) (1973) Amniotic Fluid, Research and Clinical Application. Amsterdam, Excerpta MedicaGoogle Scholar
  97. 97.
    Farber S, Cohen J, Uzman LL (1957) Lipogranulo-matosis: A new lipoglycoprotein “storage” disease. J Mt Sinai Hosp 24: 816Google Scholar
  98. 98.
    Field RA (1970) Glycogen deposition diseases. In Metabolic Basis of Inherited Disease, 2nd ed. Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) New York, McGraw-Hill, pp 141–177Google Scholar
  99. 99.
    Finkelstein JD, Mudd SH, Irreverre F, Laster L (1964) Homocystinuria due to cystathionine synthetase deficiency: Mode of inheritance. Science 146: 785PubMedCrossRefGoogle Scholar
  100. 100.
    Fluharty AL, Porter MT, Lassila EL, Trammell J, Carrel RE, Kihara H (1970) Acid glycosidases in mucopolysaccharidoses’ fibroblasts. Biochem Med 4: 110CrossRefGoogle Scholar
  101. 101.
    Forbes GB (1953) Glycogen storage disease. J Pediatr 42: 645PubMedCrossRefGoogle Scholar
  102. 102.
    Foreman DT, Grayson BA (1973) Lecithin-sphin-gomyelin ratio in amniotic fluid. Am Assoc Clin Chem Symp Amniotic Fluid, ChicagoGoogle Scholar
  103. 103.
    Forrester JS, Swan HJC (1971) “I-Cell” disease: Leakage of lysosomal enzymes into extracellular fluids. N Engl J Med 285: 1090CrossRefGoogle Scholar
  104. 104.
    Fratantoni JC, Hall CW, Neufeld EF (1966) The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation. Proc Natl Acad Sci USA 64: 360CrossRefGoogle Scholar
  105. 105.
    Fratantoni JC, Neufeld EF, Uhlendorf BW, Jacobson CB (1969) Intrauterine diagnosis of the Hurler and Hunter syndromes. N Engl J Med 280: 686PubMedCrossRefGoogle Scholar
  106. 106.
    Freda V (1965) The Rh problem in obstetrics and a new concept of its management using amniocentesis and spectrophotometric scanning of amniotic fluid. Am J Obstet Gynecol 92: 3Google Scholar
  107. 107.
    Fuchs F (1966) Volume of amniotic fluid at various stages of pregnancy. Clin Obstet Gynecol 9: 449PubMedCrossRefGoogle Scholar
  108. 108.
    Gerritsen T, Vaughn JG, Waisman HA (1962) The identification of homocystine in the urine. Biochem Biophys Res Commun 9: 493PubMedCrossRefGoogle Scholar
  109. 109.
    Gibbs GE, Griffin GD (1970) β-Glucuronidase activity in skin components of children with cystic fibrosis. Science 167: 983Google Scholar
  110. 110.
    Gitzelmann R (1967) Hereditary galactokinase deficiency, a newly recognized cause of juvenile cataracts. Pediatr Res 1: 14CrossRefGoogle Scholar
  111. 111.
    Gluck L, Kulovich MV (1973) Lecithin/sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy. Am J Obstet Gynecol 115: 539PubMedGoogle Scholar
  112. 112.
    Gluck L, Kulovich MV, Borer RC, Brenner PH, Anderson GG, Spellacy WN (1971) Diagnosis of respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol 109: 440PubMedGoogle Scholar
  113. 113.
    Gluck L, Kulovich MV, Eidelman AI, Cordero L, Khazin A (1972) Biochemical development of surface activity in mammalian lung. IV. Pulmonary lecithin synthesis in the human fetus and newborn and the etiology of the respiratory distress syndrome. Pediatr Res 6: 81PubMedCrossRefGoogle Scholar
  114. 114.
    Gluck L, Landowne RA, Kulovich MV (1970) Biochemical development of surface activity in mammalian lung. III. Structural changes in lung lecithin during development of the rabbit fetus and newborn. Pediatr Res 4: 352PubMedCrossRefGoogle Scholar
  115. 115.
    Gluck L, Motoyama EK, Smits HL, Kulovich MV (1967) The biochemical development of surface activity in mammalian lung Pediatr Res 1: 237PubMedCrossRefGoogle Scholar
  116. 116.
    Gluck L, Scibney M, Kulovich MV (1967) The biochemical development of surface activity in mammalian lung. II. The biosynthesis of phospholipids in the lung of the developing rabbit fetus and newborn. Pediatr Res 1: 247PubMedCrossRefGoogle Scholar
  117. 117.
    Goedde HW, Keller W (1967) Metabolic pathways in maple syrup urine disease. In Amino Acid Metabolism and Genetic Variations, Nyhan WL (ed) New York, McGraw-Hill Book Co, p 191Google Scholar
  118. 118.
    Goedde HW, Langebeck U, Brackertz D (1968) Detection of heterozygotes in maple syrup urine disease: role of lymphocyte count. Humangenetik 6: 189PubMedCrossRefGoogle Scholar
  119. 119.
    Goldman H, Scriver CR, Aaron K, Delvin E, Canlas Z (1971) Adolescent cystinosis: Comparisons with infantile and adult forms. Pediatrics 47: 979PubMedGoogle Scholar
  120. 120.
    Goodman SI, Pollak S, Miles B, O’Brien D (1969) The treatment of maple syrup urine disease. Pediatrics 75: 485CrossRefGoogle Scholar
  121. 121.
    Gottesfeld KR, Thompson HE, Holmes JH, Taylor ES (1970) Ultrasonic placentography: A new method for placental localization. Am J Obstet Gynecol 96: 538Google Scholar
  122. 122.
    Greene HL, Hug G, Schubert WK (1969) Metachromatic leukodystrophy. Treatment with arylsulfatase-A. Arch Neurol 20: 147PubMedCrossRefGoogle Scholar
  123. 123.
    Gribetz I, Frank NR, Avery ME (1959) Static volume-pressure relations of excised lungs of infants with hyaline membrane disease, newborn and stillborn infants. J Clin Invest 38: 2168PubMedCrossRefGoogle Scholar
  124. 124.
    Gruenwald P, Johnson RP, Hustead RF, Clements JA (1962) Correlation of mechanical properties of infant lungs with surface activity of extracts. Proc Soc Exp Biol Med 109: 369PubMedCrossRefGoogle Scholar
  125. 125.
    Guggenheim EA (1959) Thermodynamics. Amsterdam, North-Holland Publishing p 267Google Scholar
  126. 126.
    Hackett TN Jr, Hackett RJ, Bray PF, Madsen JA (1971) Chemical detection of metachromatic leukodys-trophy in disease and carrier states. Am J Dis Child 122: 223PubMedGoogle Scholar
  127. 127.
    Hagberg B, Kollberg H, Sourander P, Akesson HO (1969) Infantile globoid cell leukodystrophy (Krabbe’s disease): A clinical and genetic study of 32 Swedish cases, 1953–1967. Neuropediatrie 1: 75Google Scholar
  128. 128.
    Haggard ME, Lockhart LH (1967) Megaloblastic anemia and orotic aciduria. A hereditary disorder of pyri-midine metabolism responsive to uridine. Am J Dis Child 113: 733PubMedGoogle Scholar
  129. 129.
    Hanai J, Leroy JG, O’Brien JS (1971) Ultrastructure of cultured fibroblasts in I-cell disease. Am J Dis Child 122: 34PubMedGoogle Scholar
  130. 130.
    Harding P, Possmayer F, Milne K, Jaco NT, Walters JH (1973) Amniotic fluid phospholipids and fetal maturity. Am J Obstet Gynecol 115: 298PubMedGoogle Scholar
  131. 131.
    Harris H, Penrose LS, Thomas DHH (1959) Cystathioninuria. Ann Hum Genet 23: 442PubMedCrossRefGoogle Scholar
  132. 132.
    Herndon JH Jr, Steinberg D, Uhlendorf BW (1969) Refsum’s disease: Defective oxidation of phytanic acid in tissue cultures derived from homozygotes and heterozygotes. N Engl J Med 281: 1034PubMedCrossRefGoogle Scholar
  133. 133.
    Herndon JH Jr, Steinberg D, Uhlendorf BW, Fales HM (1969) Refsum’s disease: Characterization of the enzyme defect in cell culture. J Clin Invest 48: 1017PubMedCrossRefGoogle Scholar
  134. 134.
    Hirose G, Bass NH (1972) Metachromatic leukodystrophy in the adult. Neurology 22: 313CrossRefGoogle Scholar
  135. 135.
    Ho MW, O’Brien JS (1971) Gaucher’s disease: Deficiency of ‘acid’ β-glucosidase and reconstitution of enzyme activity in vitro. Proc Natl Acad Sci USA 68: 2810PubMedCrossRefGoogle Scholar
  136. 136.
    Ho MW, O’Brien JS (1969) Hurler’s syndrome: Deficiency of a specific β-galactosidase isoenzyme. Science 165: 611PubMedCrossRefGoogle Scholar
  137. 137.
    Ho MW, Seck J, Schmidt D, Veath ML, Johnson W, Brady RO, O’Brien JS (1972) Adult Gaucher’s disease: Kindred studies and demonstration of a deficiency of acid β-glucosidase in cultured fibroblasts. Am J Hum Genet 24: 37PubMedGoogle Scholar
  138. 138.
    Hobbins JC, Brock W, Speroff L, Anderson GG, Caldwell B (1972) L/S ratio in predicting pulmonary maturity in utero. Obstet Gynecol 39: 660PubMedGoogle Scholar
  139. 139.
    Holtz AI, Uhlendorf BW, Fredrickson DS (1964) Persistence of a lipid defect in tissue cultures derived from patients with Niemann-Pick disease. Fed Proc 23: 129Google Scholar
  140. 140.
    Holzel A (1969) Galactosemia. In: Endocrine and Genetic Diseases of Childhood, Gardner LI (ed) Philadelphia, W. B. Saunders, p 823Google Scholar
  141. 141.
    Howell RR (1972) Acatalasia and orotic aciduria, In: Antenatal Diagnosis, Dorfman A (ed) Chicago, University of Chicago Press, pp 145–149Google Scholar
  142. 142.
    Howell RR, Kaback MM, Brown BI (1970) Type IV glycogen storage disease: Branching enzyme deficiency in skin fibroblasts and possible heterozygote detection. Presented at the annual meeting of the American Pediatric Society and the Society for Pediatric Research, Atlantic City, N.J., April 29-May 2Google Scholar
  143. 143.
    Hsia DY-Y, Walker FA (1961) Variability in the clinical manifestations of galactosemia. J Pediatr 59: 872PubMedCrossRefGoogle Scholar
  144. 144.
    Hsia YE, Lilljeqvist AC, Rosenberg LE (1970) Vitamin B12 dependent methylmalonicaciduria: Amino acid toxicity, long chain ketonuria, and protective effect of vitamin B12. Pediatrics 46: 497PubMedGoogle Scholar
  145. 145.
    Hsia YE, Scully KJ, Rosenberg LE (1970) Inherited proprionyl-CoA carboxylase deficiency in “ketotic hyperglycinemia.” Presented at the annual meeting of the American Pediatric Society and the Society for Pediatric Research, Atlantic City, N.J., April 29-May 2Google Scholar
  146. 146.
    Hug G, Schubert WK, Soukup S (1971) Electron microscopy of uncultured amniotic fluid cells: In utero diagnosis of Type II glycogenosis. Abstracts Am Pediatr Soc Soc Pediatr Res, Atlantic City, April, p 118Google Scholar
  147. 147.
    Huijing F, Van Creveld S, and Losekoot G (1963) Diagnosis of generalized glycogen storage disease (Pompe’s disease). J Pediatr 63: 984PubMedCrossRefGoogle Scholar
  148. 148.
    Hummler K, Zajac BA, Genel M, Holtzapple PG, Segal S (1970) Human cystinosis: Intracellular deposition of cystine. Science 168: 859CrossRefGoogle Scholar
  149. 149.
    Hutchinson DL, Hunter CB, Nelsen ED, Pienti AA (1955) The exchange of water and electrolytes in the mechanism of amniotic fluid formation and the relationship to hydramnios. Surg Gynecol Obstet 100: 391PubMedGoogle Scholar
  150. 150.
    Illingworth B, Cori GT (1952) Structures of glycogens and amylopectins. III. Normal and abnormal human glycogen. J Biochem 199: 653Google Scholar
  151. 151.
    Jacoby LB, Littlefield JW, Milunsky A, Shih VE, Wilroy RS (1972) Argininosuccinase deficiency in cultured human cells. Am J Hum Genet 24: 321PubMedGoogle Scholar
  152. 152.
    Jatzkewitz H, Mehl E (1969) Cerebroside-sulpha-tase and arylsulphatase A deficiency in metachromatic leukodystrophy (ML). J Neurochem 16: 19PubMedCrossRefGoogle Scholar
  153. 153.
    Jeffcoate TNA, Fliegner JRH, Russell SH, Davis JC, Wade AP (1965) Diagnosis of the adrenogenital syndrome before birth. Lancet ii: 553CrossRefGoogle Scholar
  154. 154.
    Kaback MM, Howell RR (1970) Infantile metachromatic leukodystrophy: Heterozygote detection in skin fibroblasts and possible applications to intrauterine diagnosis. N Engl J Med 282: 1336PubMedCrossRefGoogle Scholar
  155. 155.
    Kahlke W (1967) Heredopathia atactica polyneu-ritiformis (Refsum’s disease). In: Lipids and Lipidoses, Shettler G (ed) New York, Springer-Verlag, pp 352–381CrossRefGoogle Scholar
  156. 156.
    Kaplan D (1969) Classification of the mucopolysaccharidoses based on the pattern of mucopolysaccharidu-ria. Am J Med 47: 721PubMedCrossRefGoogle Scholar
  157. 157.
    Kerenyi T, Sarkozi L (1974) Diagnosis of fetal death in utero by elevated amniotic fluid CPK levels. Obstet Gynecol 44: 215PubMedGoogle Scholar
  158. 158.
    Kint JA, Dacremont G, Vlietinck R (1969) Type II GM1 gangliosidosis? Lancet ii: 108Google Scholar
  159. 159.
    Kish MY, Marko J, Letts H (1970) Bilirubin estimation in amniotic fluid. A comparative study of 60 cases. Am J Obstet Gynecol 106: 592PubMedGoogle Scholar
  160. 160.
    Kiyasu J, Mathur R (1973) Considerations in determining lecithin/sphingomyelin ratio in amniotic fluid. Clin Chem 19: 1224PubMedGoogle Scholar
  161. 161.
    Kjellman B, Gamstorp I, Brun A, Ockerman PA, Palmgren B (1969) Mannosidosis: A clinical and histopathologic study. J Pediatr 75: 366Google Scholar
  162. 162.
    Klaus MH, Clements JA, Havel RJ (1961) Composition of surface-active material isolated from beef lung. Proc Natl Acad Sci USA 47: 1858PubMedCrossRefGoogle Scholar
  163. 163.
    Knox EG, Fairweather DVI, Walker W (1965) Spectrophotometric measurements on liquor amnii in relation to the severity of haemolytic disease of the newborn. Clin Sci 28: 147PubMedGoogle Scholar
  164. 164.
    Kolodny EG, Uhlendorf BW, Quirk JM, Jacobson CB, Brady RO, (1969) Gangliosides in cultured skin fibroblasts: Accumulation in Tay-Sachs disease. Presented at the Twelfth International Congress on Biochemistry of Lipids, Athens, Greece, September 7–11Google Scholar
  165. 165.
    Komrower GJ, Lambert AM, Cusworth DC, Westall RG (1966) Dietary treatment of homocystinuria. Arch Dis Child 41: 66CrossRefGoogle Scholar
  166. 166.
    Krabbe K (1916) A new familial infantile form of diffuse brain-sclerosis Brain 39: 74Google Scholar
  167. 167.
    Kresse H, Wiesmann U, Cantz M, Hall CW, Neufeld EF (1971) Biochemical heterogeneity of the Sanfilippo syndrome: Preliminary characterization of two deficient factors. Biochem Biophys Res Commun 42: 892PubMedCrossRefGoogle Scholar
  168. 168.
    Kretchmer N, Greenberg RE, Sereni F (1963) Biochemical basis of immaturity. In: Annual Review of Medicine, Degraff AC (ed) Palo Alto, Calif., Annual Reviews, Inc., Vol. 14, pp 407–426Google Scholar
  169. 169.
    Krone W, Schneider G, Schulz D (1970) Detection of phosphohexose isomerase deficiency in human fibroblast cultures. Humangenetick 10: 224CrossRefGoogle Scholar
  170. 170.
    Krooth RS (1964) Properties of diploid cell strains developed from patients with an inherited abnormality of uridine biosynthesis. Symp Quant Biol 29: 189CrossRefGoogle Scholar
  171. 171.
    Krooth RS, Howell RR, Hamilton HB (1962) Properties of acatalasic cells growing in vitro. J Exp Med 115: 313PubMedCrossRefGoogle Scholar
  172. 172.
    Krooth RS, Weinberg AN (1961) Studies on cell lines developed from the tissue of patients with galactosemia. J Exp Med 113: 1155PubMedCrossRefGoogle Scholar
  173. 173.
    Kulkarni BD, Bieniarz J, Burd L, Scommegna A (1972) Determination of lecithin sphingomyelin ratios in amniotic fluid. Obstet Gynecol 40: 173PubMedGoogle Scholar
  174. 174.
    Kulovich MV, Hallman MB, Gluck L (1979) The lung profile. I. Normal pregnancy. Am J Obstet Gynecol 135: 57PubMedGoogle Scholar
  175. 175.
    Kyriakides EC, Filippone N, Paul B, Grattan W, Balint JA (1970) Lipid studies in Wolman’s disease. Pediatrics 46: 431PubMedGoogle Scholar
  176. 176.
    Lake BD, Patrick AD (1970) Wolman’s disease: deficiency of E600-resistant acid esterase activity with storage of lipids in lysosomes. J Pediatr 76: 262PubMedCrossRefGoogle Scholar
  177. 177.
    Langenbeck U, Rudiger HW, Schulze-Schencking M, Keller W, Brackertz D, Goedde HW (1971) Evaluation of a heterozygote test for maple syrup urine disease in leucocytes and cultured fibroblasts. Humangenetik 11: 304PubMedCrossRefGoogle Scholar
  178. 178.
    Leob H, Tondeur M, Jonniaux G, Mockel-Pohl S, Vamos-Hurwitz E, (1969) Biochemical and ultrastructural studies in a case of mucopolysaccharidosis “F” (fucosi-dosis). Helv Paediatr Acta 36: 519Google Scholar
  179. 179.
    Leroy JG, DeMars RI (1967) Mutant enzymatic and cytological phenotypes in cultured human fibroblasts. Science 157: 804PubMedCrossRefGoogle Scholar
  180. 180.
    Leroy JG, DeMars RI, Optiz JM (1969) I-cell disease. The first conference on the clinical delineation of birth defects. Part 4. Skeletal dysplasias. Birth Defects (original article series No. 4) 5: 174Google Scholar
  181. 181.
    Leroy JG, Dumon J, Radermecker J (1970) Deficiency of arylulphatase A in leucocytes and skin fibroblasts in juvenile metachromatic leucodystrophy. Nature (London) 226: 553CrossRefGoogle Scholar
  182. 182.
    Leroy JG, Spranger JW (1970) I-cell disease. N Engl J Med 283: 598Google Scholar
  183. 183.
    Leroy JG, Spranger JW, Feingold M, Optiz JM, Crocker AC (1971) I-cell disease: A clinical picture. J Pe-diatr 79: 360CrossRefGoogle Scholar
  184. 184.
    Levin B (1967) Argininosuccinic aciduria. Am J Dis Child 113: 162PubMedGoogle Scholar
  185. 185.
    Levin B, Russell A (1967) Treatment of hyperammonemia. Am J Dis Child 133: 142Google Scholar
  186. 186.
    Levy HL, Shih VE, MacCready RA (1971) Inborn errors of metabolism and transport: Prenatal and neonatal diagnosis. Proceedings of the 13th International Congress of Pediatrics. Genetics, Vol. 1, Vienna, August 29Google Scholar
  187. 187.
    Lightbody J, Wiesmann U, Hadorn B, Hersch-kowitz NN (1971) I-cell disease: Multiple lysosomal-enzyme defect. Lancet i: 451CrossRefGoogle Scholar
  188. 188.
    Liley AW (1961) Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol 82: 1359PubMedGoogle Scholar
  189. 189.
    Liley AW (1972) Disorders of amniotic fluid. In: Pathophysiology of Gestation, Assali NS (ed) New York, Academic Press, Vol. 11, pp 154–206Google Scholar
  190. 190.
    Lind T (1972) Fetal control of fetal fluids. In Physiological Biochemistry of the Fetus, Hodari AA, Mariona F (eds) Springfield, Ill., Charles C Thomas, pp 54–65Google Scholar
  191. 191.
    Lind T (1973) The biochemistry of amniotic fluid. In Amniotic Fluid, Research and Clinical Application, Fairweather DVI, Eskes TKE (eds) Amsterdam, Excerpta Medica, pp 60–81Google Scholar
  192. 192.
    Lindblad B, Lindblad BS, Olin P, Svanberg B, Zetterstrom (1968) Methylmalonic acidemia: A disorder associated with acidosis, hyperglycinemia, and hyperlac-tatemia. Acta Paediatr Scand 57: 417PubMedCrossRefGoogle Scholar
  193. 193.
    Lipshaw LA, Weinberg JH, Sherman AI, Foa PP (1973) A rapid method for measuring the lecithin-sphingomyelin ratio in amniotic fluid. Obstet Gynecol 42: 93PubMedGoogle Scholar
  194. 194.
    Lonsdale E, Faulkner WR, Price JW, Smeby RR (1969) Intermittent cerebellar ataxia associated with hyperpyruvicemic acidemia, hyperalanemia and hyperalanuria. Pediatrics 43: 1025PubMedGoogle Scholar
  195. 195.
    Lyon ICT, Procopis PG, Turner B (1971) Cystathioninuria in a well baby population. Acta Paediatr Scand 60: 324PubMedCrossRefGoogle Scholar
  196. 196.
    MacBrinn M, Okada S, Woollacott M, Patel B, Ho MW, Tappel AL, O’Brien JS (1969) β-Galactosidase deficiency in the Hurler syndrome. N Engl J Med 281: 338Google Scholar
  197. 197.
    Mahoney MJ, Hsia YE, Rosenberg L (1972) Abnormalities of vitamin B12 metabolism. In Antenatal Diagnosis, Dorfman A (ed) Chicago, University of Chicago Press, pp 95–100Google Scholar
  198. 198.
    Mahoney MJ, Rosenberg JE (1971) Defective metabolism of vitamin B12 in fibroblasts from children with methylmalonicaciduria. Biochem Biophys Res Commun 44: 375PubMedCrossRefGoogle Scholar
  199. 199.
    Mallikarjuneswara VR (1975) Lecithin-sphingo-myelin ratio in amniotic fluid, as assessed by a modified thin-layer chromatographic method in which a commercial pre-coated plate is used. Clin Chem 21: 260PubMedGoogle Scholar
  200. 200.
    Malmqvist E, Ivemark BI, Lindsten J, Mauns-bach AB, Martensson E (1971) Pathologic lysosomes and increased urinary glycosylceramide excretion in Fabry’s disease. Lab Invest 25: 1PubMedGoogle Scholar
  201. 201.
    Mapes CA, Anderson RL, Sweeley CC Desnick RJ, Krivit W (1970) Enzyme replacement in Fabry’s disease, an inborn error of metabolism. Science 169: 987PubMedCrossRefGoogle Scholar
  202. 202.
    Mason RJ, Nellenbogen J, Clements JA (1976) Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res 17: 281PubMedGoogle Scholar
  203. 203.
    Matalon R, Cifonelli JA, Dorfman A (1971) L-Iduronidase in cultured human fibroblasts and liver. Biochem Biophys Res Commun 42: 340PubMedCrossRefGoogle Scholar
  204. 204.
    Matalon R, Dorfman A (1968) Acid mucopolysaccharides in cultured fibroblasts of cystic fibrosis of the pancreas. Biochem Biophys Res Commun 33: 954Google Scholar
  205. 205.
    Matalon R, Dorfman A (1968) The accumulation of hyaluronic acid in cultured fibroblasts of the Marfan syndrome. Biochem Biophys Res Commun 32: 150PubMedCrossRefGoogle Scholar
  206. 206.
    Matalon R, Dorfman A (1969) Acid mucopolysaccharides in cultured human fibroblasts. Lancet ii: 838Google Scholar
  207. 207.
    Matalon R, Dorfman A, Dawson G, Sweeley CC (1969) Glycolipid and mucopolysaccharide abnormality in fibroblasts of Fabry’s disease. Science 164: 1522PubMedCrossRefGoogle Scholar
  208. 208.
    Matalon R, Dorfman A, Nadler HL, Jacobson CB (1970) A chemical method for the antenatal diagnosis of mucopolysaccharidoses. Lancet i: 83CrossRefGoogle Scholar
  209. 209.
    McKusick VA (1966) Heritable Disorders of Connective Tissue, 3rd ed. St. Louis, C. V. MosbyGoogle Scholar
  210. 210.
    McMurray WC, Mohyuddin F, Rossiter RJ, Rath-bun JC, Valentine GH, Koegler SJ, Zarfas DE (1962) Cit-rullinuria: A new aminoaciduria associated with mental retardation. Lancet i: 138CrossRefGoogle Scholar
  211. 211.
    Mehl E, Jatzkewitz H (1968) Cerebroside 3-sul-fate as a physiological substrate of arylsulfatase A. Biochim Biophys Acta 151: 619PubMedCrossRefGoogle Scholar
  212. 212.
    Menees TO, Miller JD, Holly LE (1930) Amniog-raphy. Preliminary report. Am J Roentgenol 24: 363Google Scholar
  213. 213.
    Menkes JH, Hurst PL, Craig JM (1954) A new syndrome: Progressive familial cerebral dysfunction with an unusual urinary substance. Pediatrics 14: 462PubMedGoogle Scholar
  214. 214.
    Merkatz IR, Aladjem S, Little B (1974) The value of biochemical estimations on amniotic fluid in management of the high-risk pregnancy. In Clinics in Perinatology, Milunksy A (ed) Philadelphia, W. B. Saunders Co., Vol 1:2, pp 301–319Google Scholar
  215. 215.
    Merkatz IB, New MI, Peterson RE, Seamon MP (1969) Prenatal diagnosis of adrenogenital syndrome by amniocentesis. J Pediatr 75: 977PubMedCrossRefGoogle Scholar
  216. 216.
    Milunsky A (1970) Prenatal genetic diagnosis II. N Engl J Med 283: 1441PubMedCrossRefGoogle Scholar
  217. 217.
    Milunsky A (1973) The Prenatal Diagnosis of Hereditary Disorders. Springfield, Ill., Charles C Thomas, pp 62–135Google Scholar
  218. 218.
    Milunsky A, Alpert E (1974) The value of α;-feto-protein in prenatal diagnosis of neural tube defects. J Pe-diatr 84: 889CrossRefGoogle Scholar
  219. 219.
    Milunsky A, Littlefield JW (1969) Diagnostic limitations of metachromasia. N Engl J Med 281: 1128PubMedCrossRefGoogle Scholar
  220. 220.
    Milunsky A, Littlefield JW, Kanfer JN, Kolodny EH, Shih VE, Atkins L (1970) Prenatal genetic diagnosis I. N Engl J Med 283: 1370PubMedCrossRefGoogle Scholar
  221. 221.
    Misenheimer HR (1964) Amniotic fluid analysis in the prenatal diagnosis of erythroblastosis fetalis. Obstet Gynecol 23: 485Google Scholar
  222. 222.
    Morris MD, Fisher DA, Fiser R (1966) Late-onset branched-chain ketoaciduria (maple syrup urine disease). Lancet 86: 149Google Scholar
  223. 223.
    Morrow G (1967) Citrullinemia. Am J Dis Child 113: 157Google Scholar
  224. 224.
    Morrow G III, Mellman WJ, Barness LA, Dimitrov NV (1969) Propionate metabolism in cells cultured from a patient with methylmalonic acidemia. Pediatr Res 3: 217PubMedCrossRefGoogle Scholar
  225. 225.
    Morrow G III, Schwarz RH, Hallock JA (1970) Prenatal detection of methylmalonic acidemia. J Pediatr 77: 120CrossRefGoogle Scholar
  226. 226.
    Moser HW, Prensky AL, Wolfe HJ, Rosman NP (1969) Farber’s lipogranulomatosis—Report of a case and demonstration of an excess of free ceramide and ganglio-side. Am J Med 47: 869PubMedCrossRefGoogle Scholar
  227. 227.
    Mudd HS, Uhlendorf BW, Hinds KR, Levy HL (1970) Deranged B12 metabolism: Studies of fibroblasts grown in tissue culture. Biochem Med 4: 215PubMedCrossRefGoogle Scholar
  228. 228.
    Müller WE, Jamazaki Z, Zahn RK, Brehm G, Korting G (1971) RNA dependent DNA polymerase in cells of xeroderma pigmentosum. Biochem Biophys Res Commun 44: 433PubMedCrossRefGoogle Scholar
  229. 229.
    Murphy JV, Wolfe HJ, Balazs EA, Moser HW (1971) A patient with deficiency of arylsulfatases A, B, C and steroid sulfatase, associated with storage of sulfatide, cholesterol sulfate and glycosaminoglycans. In Lipid Storage Diseases: Enzymatic Defects and Clinical Implications, Bernsohn J (ed) New York, Academic PressGoogle Scholar
  230. 230.
    Murphy JV, Wolfe HL, Moser HW (1971) Multiple sulfatase deficiencies in a variant form of metachromatic leukodystrophy. In Lipid Storage Disease: Enzymatic Defects and Clinical Implications, Bernsohn J (ed) New York, Academic PressGoogle Scholar
  231. 231.
    Myrianthopoulos NC, Aronson SM (1966) Population dynamics of Tay-Sachs disease. I. Reproductive fitness and selection. Am J Hum Genet 18: 313PubMedGoogle Scholar
  232. 232.
    Nadler HL (1968) Patterns of enzyme development utilizing cultivated human fetal cells derived from amniotic fluid. Biochem Genet 2: 119PubMedCrossRefGoogle Scholar
  233. 233.
    Nadler HL (1968) Antenatal detection of hereditary disorders. Pediatrics 42: 912PubMedGoogle Scholar
  234. 234.
    Nadler HL (1971) Genetic heterogeneity in acid phosphatase deficiency. Abstracts Am Pediat Soc Soc Pe-diat Res, Atlantic City, April, p 117Google Scholar
  235. 235.
    Nadler HL (1975) Prenatal Diagnosis of Inborn Defects: A Status Report. Hosp Pract Vol. 10, 6: 41Google Scholar
  236. 236.
    Nadler HL, Burton BK (1973) Enzymes in the amniotic fluid and the prenatal diagnosis of inborn errors of metabolism. In Amniotic Fluid. Fairweather DVI, Eskes TKA (eds) Amsterdam, Excerpta Medica, pp 223–261Google Scholar
  237. 237.
    Nadler HL, Egan TJ (1970) Deficiency of lysosomal acid phosphatase: A new familial metabolic disorder. N Engl J Med 282: 302PubMedCrossRefGoogle Scholar
  238. 238.
    Nadler HL, Gerbie AB (1969) Enzymes in non-cultured amniotic fluid cells. Am J Obstet Gynecol 103: 710PubMedGoogle Scholar
  239. 239.
    Nadler HL, Gerbie AB (1971) Present status of amniocentesis in intrauterine diagnosis of genetic defects. Obstet Gynecol 38: 389Google Scholar
  240. 240.
    Nadler HL, Messina AM (1969) In-utero detection of type-II glycogenosis (Pompe’s disease). Lancet ii: 1277CrossRefGoogle Scholar
  241. 241.
    Nadler HL, Wodnicki JM, Swae MA, O’Flynn ME (1969) Cultivated amniotic fluid cells and fibroblasts derived from families with cystic fibrosis. Lancet ii: 84CrossRefGoogle Scholar
  242. 242.
    Natelson S, Scommegna A, Epstein MB (eds) (1974) Amniotic Fluid. New York, John Wiley and sonsGoogle Scholar
  243. 243.
    Nelson GH (1969) Amniotic fluid phospholipid patterns in normal and abnormal pregnancies. Am J Obstet Gynecol 105: 1072PubMedGoogle Scholar
  244. 244.
    Nelson GH, Lawson SW (1973) Determination of amniotic fluid total phospholipid phosphorus as a test for fetal lung maturity. Am J Obstet Gynecol 115: 933PubMedGoogle Scholar
  245. 245.
    Neufeld EF, Cantz MJ (1971) Corrective factors for inborn errors of mucopolysaccharide metabolism. Ann NY Acad Sci 179: 580PubMedCrossRefGoogle Scholar
  246. 246.
    Neufeld EF, Fratantoni JC (1970) Inborn errors of mucopolysaccharide metabolism. Science 169: 141PubMedCrossRefGoogle Scholar
  247. 247.
    Nichols J (1969) Antenatal diagnosis of adrenocortical hyperplasia. Lancet i: 1151Google Scholar
  248. 248.
    Nichols J, Gibson GG (1969) Antenatal diagnosis of the adrenogenital syndrome. Lancet ii: 1068Google Scholar
  249. 249.
    Nitowsky HM, Grunefeld A (1967) Lysomal, α-glucosidase in type-II glycogenosis: Activity in leukocytes and cell cultures in relation to genotype. J Lab Clin Med 69: 472PubMedGoogle Scholar
  250. 250.
    Novy MJ (1973) Evaluation and treatment of the fetus at risk. In: Neonatology. Diseases of the Fetus and Infant, Behrman RE (ed) Saint Louis, The C. V. Mosby Company, pp 2–4Google Scholar
  251. 251.
    Oberholzer VG, Levin B, Burgess A, Young WF (1967) Methylmalonic aciduria: an inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child 42: 492PubMedCrossRefGoogle Scholar
  252. 252.
    O’Brien J (1969) Generalized gangliosidosis. J Pediatr 75: 167PubMedCrossRefGoogle Scholar
  253. 253.
    O’Brien JS (1972) Sanfilippo syndrome: Profound deficiency of α-acetylglucosaminidase activity in organs and skin fibroblasts from type-B patients. Proc Natl Acad Sci USA 69: 1720PubMedCrossRefGoogle Scholar
  254. 254.
    O’Brien JS, Okada S, Chen A, Fillerup DL (1970) Tay-Sachs disease: Detection of heterozygotes and homozygotes by serum hexosaminidase assay. N Engl J Med 283: 15PubMedCrossRefGoogle Scholar
  255. 255.
    O’Brien JS, Okada S, Fillerup DL, Veath ML, Adornato B, Brenner PH, Leroy JG (1971) Tay-Sachs disease: prenatal diagnosis. Science 172: 61PubMedCrossRefGoogle Scholar
  256. 256.
    O’Brien JS, Okada S, Ho MW, Fillerup DL, Veath ML, Adams K (1971) Ganglioside-storage diseases. Fed Proc 30: 956PubMedGoogle Scholar
  257. 257.
    O’Brien JS, Stern MD, Landing BH, O’Brien JK, Donnell GN (1965) Generalized gangliosidosis: Another inborn error of ganglioside metabolism? Am J Dis Child 109: 338PubMedGoogle Scholar
  258. 258.
    Ockerman PA (1969) Mannosidosis: Isolation of oligosaccharide storage material from brain. J Pediatr 75: 360PubMedCrossRefGoogle Scholar
  259. 259.
    Okada S, O’Brien JS (1968) Generalized gangliosidosis: β-Galactosidase deficiency. Science 160: 1002PubMedCrossRefGoogle Scholar
  260. 260.
    Okada S, O’Brien JS (1969) Tay-Sachs disease: Generalized absence of a β-D-AAacetylhexosaminidase component. Science 165: 698PubMedCrossRefGoogle Scholar
  261. 261.
    Okada S, Veath ML, Leroy J, O’Brien JS (1971) Ganglioside GM2 storage diseases: Hexosaminidase deficiencies in cultured fibroblasts. Am J Hum Genet 23: 55PubMedGoogle Scholar
  262. 262.
    Okada S, Veath ML, O’Brien JS (1970) Juvenile GM2 gangliosidosis: Partial deficiency of hexosaminidase A. J Pediatr 77: 1063PubMedCrossRefGoogle Scholar
  263. 263.
    Ostergard DR (1970) The physiology and clinical importance of amniotic fluid: A review. Obstet Gynecol Surv 25: 297PubMedCrossRefGoogle Scholar
  264. 264.
    Paglia DE, Holland P, Baughan MA, Valentine WN (1969) Occurrence of defective hexosephosphate isomerization in human erythrocytes and leukocytes. N Engl J Med 280: 66PubMedCrossRefGoogle Scholar
  265. 265.
    Painter CP (1980) Simultaneous measurement of lecithin, sphingomyelin, phosphatidylglycerol, phospha-tidylinositol, phosphatidylethanolamine and phosphati-dylserine in amniotic fluid. Clin Chem 26: 1147PubMedGoogle Scholar
  266. 266.
    Parmley T, Seeds AE (1970) Permeability of fetal skin to tritated water. Am J Obstet Gynecol 108: 128PubMedGoogle Scholar
  267. 267.
    Patel V, Tappel AL, O’Brien JS (1970) Hyaluronidase and sulfatase deficiency in Hurler’s syndrome. Biochem Med 3: 447PubMedCrossRefGoogle Scholar
  268. 268.
    Patrick AD, Lake BD (1969) Deficiency of an acid lipase in Wolman’s disease. Nature (London) 222:1067CrossRefGoogle Scholar
  269. 269.
    Pattle RE, Claireaux AE, Davies PA, Cameron AH (1962) Inability to form a lung lining film as a cause of respiratory distress syndrome in the newborn. Lancet ii: 469Google Scholar
  270. 270.
    Percy AK, Brady RO (1968) Metachromatic leukodystrophy: Diagnosis with samples of venous blood. Science 161: 594PubMedCrossRefGoogle Scholar
  271. 271.
    Percy AK, Kaback MM (1971) Infantile and adult-onset metachromatic leukodystrophy—Biochemical comparisons and predictive diagnosis. N Engl J Med 285: 785PubMedCrossRefGoogle Scholar
  272. 272.
    Perry TL, Dunn HG, Hansen S, MacDougall L, Warrington PD (1966) Early diagnosis and treatment of homocystinuria. Pediatrics 37: 501Google Scholar
  273. 273.
    Perry TL, Hardwick DF, Hansen S, Love DL, Israels S (1968) Cystathioninuria in two healthy siblings. N Engl J Med 278: 590PubMedCrossRefGoogle Scholar
  274. 274.
    Pfleger RC, Thomas HG (1971) Beagle dog pulmonary surfactant lipids. Arch Intern Med 127: 863PubMedCrossRefGoogle Scholar
  275. 275.
    Pitkin RM, Zwirek SJ (1967) Amniotic fluid creatinine. Am J Obstet Gynecol 98: 1135PubMedGoogle Scholar
  276. 276.
    Pienti AA (1959) The dynamics of the amniotic fluid. Ann NY Acad Med 75: 746CrossRefGoogle Scholar
  277. 277.
    Pienti AA (1966) Formation and circulation of the amniotic fluid. Clin Obstet Gynecol 9: 427CrossRefGoogle Scholar
  278. 278.
    Porter MT, Fluharty AL, Harris SE, Kihara H (1970) The accumulation of cerebroside sulfates by fibroblasts in culture from patients with late infantile metachromatic leukodystrophy. Arch Biochem Biophys 138: 646PubMedCrossRefGoogle Scholar
  279. 279.
    Porter MT, Fluharty AL, Kihara H (1969) Metachromatic leukodystrophy: Arylsulfatase-A deficiency in skin fibroblast cultures. Proc Natl Acad Sci USA 62: 887PubMedCrossRefGoogle Scholar
  280. 280.
    Porter MT, Fluharty AL, Kihara H (1971) Correction of abnormal cerebroside sulfate metabolism in cultured metachromatic leukodystrophy fibroblasts. Science 172: 1263PubMedCrossRefGoogle Scholar
  281. 281.
    Porter MT, Fluharty AL, Trammell J, Kihara H (1971) A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy. Biochem Biophys Res Commun 44: 660PubMedCrossRefGoogle Scholar
  282. 282.
    Pritchard J (1965) Deglutition by normal and anancephalic infants. Obstet Gynecol 25: 289PubMedGoogle Scholar
  283. 283.
    Rattazzi MC, Davidson RG (1970) Limitations of amniocentesis for the antenatal diagnosis of Tay-Sachs disease. Abstracts Am Soc Hum Genet Meeting, Indianapolis, October 11Google Scholar
  284. 284.
    Reed WB, Landing B, Sugarman G, Cleaver JE, Mclnyk J (1969) Xeroderma pigmentosum JAMA 207: 2073CrossRefGoogle Scholar
  285. 285.
    Regan JD, Setlow RB, Kaback MM, Howell RR, Klein E, Burgess G (1971) Xeroderma pigmentosum: A rapid sensitive method for prenatal diagnosis. Science 174: 147PubMedCrossRefGoogle Scholar
  286. 286.
    Reid DE, Ryan KJ, Benirschke K (1972) Principles and Management of Human Reproduction. Philadelphia, W. B. Saunders Company, p 410Google Scholar
  287. 287.
    Reynolds A (1972) Fetal sources of amniotic fluid: An enigma. In Physiological Biochemistry of the Fetus, Hodari AA, Mariona F (eds) Springfield, Ill., Charles C Thomas pp 3–31Google Scholar
  288. 288.
    Robinson D, Stirling JL (1968) N-Acetyl-β-gluco-saminidases in human spleen. Biochem J 107: 321PubMedGoogle Scholar
  289. 289.
    Rogers LE, Warford LR, Patterson RB, Porter FS (1968) Hereditary orotic aciduria I. A new case with family studies. Pediatrics 42: 415PubMedGoogle Scholar
  290. 290.
    Romeo G, Kaback MM, Glenn BL, Levin EY (1970) The enzymatic defect in congenital erythropoietic porphyria: Demonstration in heterozygotes and in non-erythropoietic tissue of homozygotes. Presented at the annual meeting of the American Pediatric Society and the Society for Pediatric Research, Atlantic City, April 29-May 2Google Scholar
  291. 291.
    Romeo G, Migeon BR (1970) Genetic inactiva-tion of the α-galactosidase locus in carriers of Fabry’s disease. Science 170: 180PubMedCrossRefGoogle Scholar
  292. 292.
    Ron M, Pearce J (1971) Refsum’s syndrome with normal phytate metabolism. Acta Neurol Scand 47: 646PubMedCrossRefGoogle Scholar
  293. 293.
    Roopnarinesingh S (1970) Amniotic fluid creatinine in normal and abnormal pregnancies. J Obstet Gynaecol Br Commonw 77: 785PubMedCrossRefGoogle Scholar
  294. 294.
    Rosenberg LE, Lilljeqvist AC, Hsia YE (1968) Methylmalonic aciduria: an inborn error leading to metabolic acidosis, long-chain ketonuria and intermittent hyperglycinemia. N Engl J Med 278: 1319PubMedCrossRefGoogle Scholar
  295. 295.
    Rosenberg LE, Lilljeqvist AC, Hsia YE, Rosen-bloom FE (1969) Vitamin B12 dependent methylmalonica-ciduria: defective B12 metabolism in cultured fibroblasts. Biochem Biophys Res Commun 37: 607PubMedCrossRefGoogle Scholar
  296. 296.
    Russel A, Levin B, Oberholzer VG, Sinclair L (1962) Hyperammonaemia: A new instance of an inborn enzymatic defect of the biosynthesis of urea. Lancet ii: 699CrossRefGoogle Scholar
  297. 297.
    Russell JD (1969) Variation of UDP Glu:a-DGal-1-P-uridyl transferase activity during growth of cultured fibroblasts. In Galactosemia, Hsia DY-Y (ed) Springfield, Ill., Charles C Thomas, pp 204–212Google Scholar
  298. 298.
    Russell PT, Miller WJ, McLain CR (1974) Palmitic acid content of amniotic fluid lecithin as an index to fetal lung maturity. Clin Chem 20: 1431PubMedGoogle Scholar
  299. 299.
    Sacrez R, Juif JG, Gigonnet JM, Gruner JE (1967) La maladie de Landing: Ou idiotie amaurotique infantile precoce avec gangliosidose generalisse de type GM1 Pediatrie 22: 143Google Scholar
  300. 300.
    Salafsky IS, Nadler HL (1971) α-l,4-Glucosidase activity in Pompe’s disease. J Pediatr 79: 794Google Scholar
  301. 301.
    Sandhoff K (1969) Variation of β-N-acetylhexosaminidase-pattern in Tay-Sachs disease. FEBS Lett 4: 351PubMedCrossRefGoogle Scholar
  302. 302.
    Sandhoff K, Andreae U, Jatzkewitz H (1968) Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs. Life Sci 7: 283PubMedCrossRefGoogle Scholar
  303. 303.
    Sarkozi L, Kerenyi T, Jeuell C (1973) The origin of elevated amniotic fluid CPK levels and experimental verification of the time factor in DIU (Abstr. 101). Presented at the Twenty-fifth National Meeting of the American Association of Clinical Chemists, New York, July 15–20Google Scholar
  304. 304.
    Sarkozi L, Kerenyi T, Saary Z, Hutterer F (1972) Amniotic fluid CPK and LDH in feto-placental damage and intrauterine death. Res Commun Chem Pathol Pharmacol 3: 189PubMedGoogle Scholar
  305. 305.
    Sarkozi L, Kovacs HN, Fox HS, Kerenyi T (1972) Modified methods for estimating the phosphatidylcholine: sphingomyelin ratio in amniotic fluid, and its use in the assessment of fetal lung maturity. Clin Chem 18: 956PubMedGoogle Scholar
  306. 306.
    Scarpelli EM (1969) Pulmonary surfactants and their role in lung diseases. Adv Pediatr 16: 177PubMedGoogle Scholar
  307. 307.
    Schmid R (1966) Congenital erythropoietic porphyria. In: The Metabolic Basis of Inherited Disease, Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) 2nd ed., New York, McGraw-Hill, pp 831–844Google Scholar
  308. 308.
    Schneck L, Adachi M, Volk BW (1972) The fetal aspects of Tay-Sachs disease. Pediatrics 49: 342PubMedGoogle Scholar
  309. 309.
    Schneck L, Friedland J, Pourfar M, Saifer A, Volk B (1970) Hexosaminidase activities in a case of systemic GM2 gangliosidosis of late infantile type. Proc Soc Exp Biol Med 133: 997PubMedCrossRefGoogle Scholar
  310. 310.
    Schneck L, Friedland J, Valenti C, Adachi M, Amsterdam D, Volk BW (1970) Prenatal diagnosis of Tay-Sachs disease. Lancet i: 582CrossRefGoogle Scholar
  311. 311.
    Schenck L, Volk BW (1967) Clinical manifestations of Tay-Sachs disease and Niemann-Pick disease. In: Inborn Disorders of Sphingolipid Metabolism, Aronson, SM, Volk, BW (eds) Proceedings of the Third International Symposium on the Cerebral Sphingolipidoses. Oxford, Pergamon Press, pp 403–411Google Scholar
  312. 312.
    Schenck L, Volk BW, Saifer A (1969) The gangliosidoses. Am J Med 46: 245CrossRefGoogle Scholar
  313. 313.
    Schneider AS, Valentine WN, Hattori M, Heins HL (1965) Hereditary hemolytic anemia with triosephosphate isomerase deficiency. N Engl J Med 272: 229PubMedCrossRefGoogle Scholar
  314. 314.
    Schneider JA, Rosenbloom FM, Bradley KH, Seegmiller JE (1967) Increased free-cystine content of fibroblasts cultured from patients with cystinosis. Biochem Biophys Res Commun 29: 527PubMedCrossRefGoogle Scholar
  315. 315.
    Schneider JA, Wong VG, Bradley K, Seegmiller JE (1968) Biochemical comparisons of the adult and childhood forms of cystinosis. N Engl J Med 279: 1253PubMedCrossRefGoogle Scholar
  316. 316.
    Schulman JD, Wong VG, Bradley KH, Olson WH, Seegmiller JE (1970) Cystinosis: Biochemical, morphological, and clinical studies. Pediatr Res 4: 379CrossRefGoogle Scholar
  317. 317.
    Scott CR, Dassell SW, Clark SH, Chiang-Teng C, Swedberg KR (1970) Cystathioninemia: A benign genetic condition. J Pediatr 76: 571PubMedCrossRefGoogle Scholar
  318. 318.
    Scriver CR, Mackenzie S, Clow CL, Devlin E (1971) Thiamine-responsive maple syrup urine disease. Lancet i: 310CrossRefGoogle Scholar
  319. 319.
    Seeds AE (1965) Water metabolism of the fetus. Am J Obstet Gynecol 92: 727PubMedGoogle Scholar
  320. 320.
    Seegmiller JE (1974) Amniotic fluid and cells in the diagnosis of genetic disorders. In: Amniotic Fluid, Natelson S, Scommegna A, Epstein MB (eds) New York, John Wiley and Sons pp 291–316Google Scholar
  321. 321.
    Seegmiller JE, Friedmann T, Harrison HE, Wong V, Schneider JA (1968) Cystinosis. Ann Intern Med 68: 883CrossRefGoogle Scholar
  322. 322.
    Seegmiller JE, Westall RG (1967) The enzyme defect in maple syrup urine disease (branched chain keto-aciduria). J Ment Defic Res 11: 288PubMedGoogle Scholar
  323. 323.
    Shaw RF, Smith AP (1969) Is Tay-Sachs disease increasing? Nature (London) 224: 1213CrossRefGoogle Scholar
  324. 324.
    Shelley SA, Takagi LR, Balis JU (1973) Assessment of surfactant activity in amniotic fluid in evaluation of fetal lung maturity. Am J Obstet Gynecol 116: 369PubMedGoogle Scholar
  325. 325.
    Shih VE (1972) Early dietary management of an infant with argininosuccinase deficiency. J Pediatr 80: 645PubMedCrossRefGoogle Scholar
  326. 326.
    Shih VE, Littlefìeld JW (1970) Argininosuccinase activity in amniotic fluid cells. Lancet ii: 45Google Scholar
  327. 327.
    Shih VE, Littlefìeld JW, Moser HW (1969) Argininosuccinase deficiency in fibroblasts cultured from patients with argininosuccinic aciduria. Biochem Genet 3: 81CrossRefGoogle Scholar
  328. 328.
    Shih VE, Schulman JD (1970) Ornithine-ketoacid transaminase activity in human skin and amniotic fluid cell culture. Clin Chim Acta 27: 73PubMedCrossRefGoogle Scholar
  329. 329.
    Shinitzky M, Goldfisher A, Bruck H, Goldman B, Stern E, Barkai G, Mashiach S, Serr DM (1976) A new method for assessment of fetal lung maturity. Br J Obstet Gynaecol 83: 838PubMedCrossRefGoogle Scholar
  330. 330.
    Sidbury JB Jr (1969) The glycogenoses. In: Endocrine and Genetic Diseases of Childhood, Gardner LI (ed) Philadelphia, W. B. Saunders, Co., p 853Google Scholar
  331. 331.
    Sidbury JB Jr, Mason J, Burner WB Jr, Ruebner BH (1962) Type IV glycogenosis: report of a case proven by characterization of glycogen and studied at necropsy. Bull Johns Hopkins Hosp 111: 157PubMedGoogle Scholar
  332. 332.
    Singer HS, Nankervis GA, Schafer IA (1972) Leukocyte β-galactosidase activity in the diagnosis of generalized GM1 gangliosidosis. Pediatrics 49: 352PubMedGoogle Scholar
  333. 333.
    Singer HS, Schafer IA (1970) White cell β-galac-tosidase activity. N Engl J Med 282: 571PubMedGoogle Scholar
  334. 334.
    Sloan HR (1969) β-Galactosidase deficiency in GM1 gangliosidosis: Enzymatic and histochemical studies in tissue culture. Pediatr Res 3: 368Google Scholar
  335. 335.
    Sloan HR, Uhlendorf BW, Jacobson CB, Fred-rickson DS (1969) β-Galactosidase in tissue culture derived from human skin and bone marrow: Enzyme defect in GM1 gangliosidosis. Pediatr Res 3: 532Google Scholar
  336. 336.
    Sloan HR, Uhlendorf BW, Kanfer JN, Brady RO, Fredrickson DS (1969) Deficiency of sphingomyelin-cleav-ing enzyme activity in tissue cultures derived from patients with Niemann-Pick disease. Biochem Biophys Res Commun 34: 582PubMedCrossRefGoogle Scholar
  337. 337.
    Slome DJ (1933) Genetic basis of amaurotic family idiocy. Genetics 27: 363CrossRefGoogle Scholar
  338. 338.
    Smith LH Jr, Sullivan M, Huguley CM (1961) Pyrimidine metabolism in man IV. The enzymatic defect of orotic aciduria. J Clin Invest 40: 656PubMedCrossRefGoogle Scholar
  339. 339.
    Snyderman SE (1967) Maple syrup urine disease. In Amino Acid Metabolism and Genetic Variation, Nyhan WL (ed) New York, McGraw-Hill, pp 171–183Google Scholar
  340. 340.
    Sotos JF, Romshe CA, Boggs DE, Menking MF (1969) Methylmalonic aciduria—Vitamin B12 dependent. Abst Soc Ped Res, 39th Annual Meeting, Atlantic City, May, p 13.Google Scholar
  341. 341.
    Spellacy WN, Buhl WC (1972) Amniotic fluid lecithin/sphingomyelin ratio as an index of fetal maturity. Obstet Gynecol 39: 852PubMedGoogle Scholar
  342. 342.
    Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) (1972) The Metabolic Basis of Inherited Disease, 3rd ed. New York, McGraw-Hill Book CoGoogle Scholar
  343. 343.
    Stempel LE, Lott JA (1980) Diagnosis of fetal death in utero with amniotic fluid creatine kinase. Am J Obstet Gynecol 138: 1173PubMedGoogle Scholar
  344. 344.
    Stokke O, Eldjarn L, Norum KR, Steen-Johnsen J, Halvorsen S (1967) Methylmalonic acidemia: A new inborn error of metabolism which may cause fatal acidosis in the neonatal period. Scand J Clin Lab Invest 20: 313CrossRefGoogle Scholar
  345. 345.
    Stumpf D, Austin J (1971) Metachromatic leukodystrophy (MLD). Arch Neurol 24: 117PubMedCrossRefGoogle Scholar
  346. 346.
    Sugita M, Dulaney J, Moser HW (1972) Cerami-dase deficiency in Farber’s disease (Lipogranulomatosis). Science 178: 1100PubMedCrossRefGoogle Scholar
  347. 347.
    Suzuki K, Chen GC (1967) Brain ceramide hexo-sides in Tay-Sachs disease and generalized gangliosidosis (GM1 gangliosidosis). J Lipid Res 8: 105PubMedGoogle Scholar
  348. 348.
    Suzuki K, Schneider EL, Epstein CJ (1971) In utero diagnosis of globoid cell leukodystrophy (Krabbe’s disease). Biochem Biophys Res Commun 45: 1363PubMedCrossRefGoogle Scholar
  349. 349.
    Suzuki K, Kamoshita S (1969) Chemical pathology of Gmi gangliosidosis (generalized gangliosidosis). J Neuropathol Exp Neurol 28: 25PubMedCrossRefGoogle Scholar
  350. 350.
    Suzuki K, Rapin I, Suzuki Y, Ishii N (1970) Juvenile GM1 gangliosidosis. Clinical variant of Tay-Sachs disease or a new disease. Neurology 20: 190PubMedCrossRefGoogle Scholar
  351. 351.
    Suzuki K, Suzuki Y (1970) Globoid cell leukodystrophy (Krabbe’s disease): deficiency of galactocerebroside β-galactosidase. Proc Natl Acad Sci USA 66: 302PubMedCrossRefGoogle Scholar
  352. 352.
    Suzuki Y, Berman PH, Suzuki K (1971) Detection of Tay-Sachs disease heterozygotes by assay of hexosaminidase A in serum and leukocytes. J Pediatr 78: 643PubMedCrossRefGoogle Scholar
  353. 353.
    Suzuki Y, Jacob JC, Suzuki K (1970) A case of GM1 gangliosidosis with total hexosaminidase deficiency. Neurology 20: 388PubMedCrossRefGoogle Scholar
  354. 354.
    Suzuki Y, Jacob JC, Suzuki K, Kutty KM, Suzuki K (1971) GM1 gangliosidosis with total hexosaminidase deficiency. Neurology 21: 313PubMedCrossRefGoogle Scholar
  355. 355.
    Suzuki Y, Suzuki K (1970) Partial deficiency of hexosaminidase component A in juvenile GM2 gangliosidosis. Neurology 20: 848PubMedCrossRefGoogle Scholar
  356. 356.
    Suzuki Y, Suzuki K (1971) Krabbe’s globoid cell leukodystrophy: Deficiency of galactocerebrosidase in serum, leukocytes and fibroblasts. Science 171: 73PubMedCrossRefGoogle Scholar
  357. 357.
    Sweeley CC, Klionsky B (1966) Glycolipid lipidosis: Fabry’s disease. In The Metabolic Basis of Inherited Disease, Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) 2nd ed. New York, McGraw-Hill, pp 618–632Google Scholar
  358. 358.
    Tada K, Wada Y, Arakawa T (1967) Hypervalinemia: Its metabolic lesion and therapeutic approach. Am J Dis Child 113: 64PubMedGoogle Scholar
  359. 359.
    Tedesco TA, Mellman WJ (1967) Argininosuccinate synthetase activity and citrulline metabolism in cells cultured from a citrullinemic subject. Proc Natl Acad Sci USA 57: 829PubMedCrossRefGoogle Scholar
  360. 360.
    Thorn H, Dinwiddie R, Fisher PM, Russell G, Sutherland HW (1975) Palmitic acid concentrations and lecithin/sphingomyelin ratios in amniotic fluid. Clin Chim Acta 62: 143CrossRefGoogle Scholar
  361. 361.
    Thomas GH (1969) β-D-Galactosidase in human urine: Deficiency in generalized gangliosidosis. J Lab Clin Med 74: 725PubMedGoogle Scholar
  362. 362.
    Torday J, Carson L, Lawson EE (1979) Saturated phosphatidylcholine in amniotic fluid and prediction of the respiratory distress syndrome. N Engl J Med 301: 1013PubMedCrossRefGoogle Scholar
  363. 363.
    Uhlendorf BW, Holtz AL, Mock MB, Fredrickson DS (1967) Persistence of a metabolic defect in tissue culture derived from patients with Niemann-Pick disease. In: Inborn Disorders of Sphingolipid Metabolism. Aronson SM, Volk BW (eds) Proceedings of the Third International Symposium on the Cerebral Sphingolipidoses. Oxford, Per-gamon Press, pp 403–411Google Scholar
  364. 364.
    Uhlendorf BW, Mudd SH (1968) Cystathionine synthase in tissue culture derived from human skin: Enzyme defect in homocystinuria. Science 160: 1007PubMedCrossRefGoogle Scholar
  365. 365.
    Valenti C (1974) Perinatal genetic studies and counseling. In Clinical Perinatology, Aladjem S, Brown AK (eds) Saint Louis, The C. V. Mosby Company, pp 87–139Google Scholar
  366. 366.
    Van Hoof F, Hers HG (1968) Mucopolysaccharidosis by absence of a-fucosidase. Lancet i: 1198Google Scholar
  367. 367.
    Van Hoof F, Hers HG (1968) The abnormalities of lysosomal enzymes in mucopolysaccharidoses. Eur J Biochem 7: 34PubMedCrossRefGoogle Scholar
  368. 368.
    Velia EE (1972) A chemical method for the antenatal diagnosis of mucopolysaccharidoses. Lancet i: 798Google Scholar
  369. 369.
    Volk BW, Adachi M, Schneck L, Saifer A, Kleinberg W (1969) G5-ganglioside variant of systemic late infantile lipidosis. Generalized gangliosidosis. Arch Pathol 87: 393PubMedGoogle Scholar
  370. 370.
    Wada Y, Tada K, Minagawa A, Yoshida T, Morikawa T, Okamura T (1963) Idiopathic hypervalinemia. Probably a new entity of inborn error of valine metabolism. Tohoku J Exp Med 81: 46PubMedCrossRefGoogle Scholar
  371. 371.
    Walker AHC (1957) Liquor amnii studies in the prediction of hemolitic disease of the newborn. Br Med J 2: 375Google Scholar
  372. 372.
    Warren C, Holton JB, Allen JT (1974) A method of assessing amniotic fluid lecithin concentrations and predicting foetal lung maturity, by estimating total palmitic acid concentration using G.L.C. Ann Clin Biochem 11: 31Google Scholar
  373. 373.
    Westall RG (1967) Dietary treatment of maple syrup urine disease. Am J Dis Child 113: 58PubMedGoogle Scholar
  374. 374.
    Westall RG, Dancis J, Miller S (1957) Maple sugar urine disease. Am J Dis Child 94: 571Google Scholar
  375. 375.
    White JC (1966) Viruslike particles in the peripheral blood cells of two patients with Chediak-Higashi syndrome. Cancer 19: 877PubMedCrossRefGoogle Scholar
  376. 376.
    White JC (1967) The Chediak-Higashi syndrome: Cytoplasmic sequestration in circulating leukocytes. Blood 29: 435PubMedGoogle Scholar
  377. 377.
    Wiesmann UN, Lightbody J, Vasella F, Herschkowitz NN (1971) Multiple lysosomal enzyme deficiency due to enzyme leakage? N Engl J Med 284: 109PubMedGoogle Scholar
  378. 378.
    Wiesmann UN, Neufeld EF (1970) Scheie and Hurler syndromes: Apparent identity of the biochemical defect. Science 169: 72PubMedCrossRefGoogle Scholar
  379. 379.
    Wiesmann UN, Rossi EE, Herschkowitz NN (1972) Correction of the defective sulfatide degradation in cultured fibroblasts from patients with metachromatic leukodystrophy. Acta Paediatr Scand 61: 296PubMedCrossRefGoogle Scholar
  380. 380.
    Wolfe LS, Callahan JW, Fawcett JS, Andermann F, Scriver CR (1970) GM1 gangliosidosis without chondrodystrophy or visceromegaly. β-Galactosidase deficiency with gangliosidosis and the excessive excretion of a keratan sulfate. Neurology 20: 23PubMedCrossRefGoogle Scholar
  381. 381.
    Wolman M, Sterk WV, Gatt S, Frenkel M (1961) Primary familial xanthomatosis with involvement and calcification of the adrenals. Pediatrics 28: 742PubMedGoogle Scholar
  382. 382.
    Young EP, Ellis RB, Lake BD, Patrick AD (1970) Tay-Sachs disease and related disorders: Fractionation of brain N-acetyl-β-hexosaminidase on DEAE cellulose. FEBS Lett 9: 1PubMedCrossRefGoogle Scholar
  383. 383.
    Young EP, Patrick AD (1970) Deficiency of acid esterase activity in Wolman’s disease. Arch Dis Child 45: 664PubMedCrossRefGoogle Scholar
  384. 384.
    Zielke K, Okada S, O’Brien JS (1972) Fucosidosis: Diagnosis by serum assay of α-L-fucosidase. J Lab Clin Med 79: 164PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1982

Authors and Affiliations

  • Laszlo Sarkozi

There are no affiliations available

Personalised recommendations